Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)

SHE:000952 Revenue

Hubei Guangji Pharmaceutical had revenue of 148.86M CNY in the quarter ending June 30, 2026, with 9.56% growth. This brings the company's revenue in the last twelve months to 651.57M, up 3.97% year-over-year. In the year 2025, Hubei Guangji Pharmaceutical had annual revenue of 623.97M, down -2.32%.

• Revenue (ttm): 651.57M
• Revenue Growth: +3.97%
• P/S Ratio: 3.42
• Revenue / Employee: 559.77K
• Employees: 1,164
• Market Cap: 2.23B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	623.97M	-14.83M	-2.32%
Dec 31, 2024	638.80M	-99.02M	-13.42%
Dec 31, 2023	737.82M	-59.82M	-7.50%
Jan 1, 2023	797.64M	12.07M	1.54%
Jan 1, 2022	785.57M	97.40M	14.15%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error